Skip to main content

Table 1 Baseline data: “On-diet”: 36 pregnancies in patients who followed a supplemented vegan diet in pregnancy (31 singleton deliveries)

From: Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience

Case

Age (yrs)

Pre-conceptional; Referral-week

Kidney disease

sCr mg/dL (EPI-GFR mL/min)

CKD stage

PtU (g/24 h)

Pt/Alb (g/dL)

HT

Therapy at referral

BMI

1

35

pre; ICSI

Diab neph

1.2 (59)

3

2.5

5.9/2.8

Yes

Insulin, doxazosine

23.5

2

35

pre; 8w

Diab neph

1.6 (45)

4

1.8

6.5/3.8

No

Insulin

22

3

28

7w

Sponge kidney

3.2 (19)

4

0.8

6.5/3.5

No

EPO, Vit. D

22

4

37

pre; 6w

Diab neph

1.2 (58)

3

5.9

5.8/3.2

No

Insulin

22

5

32

6w

SLE

0.7 (115)

1

2.7

6.0/3.1

Yes

Pred., ASA, omeprazole, a-MD

24

6

35

pre; 7w

Reflux

3.2 (18)

4

1.0

8.4/4.5

Yes

Vit. D, b-blocker ASA

19

7

29

9w

Diab neph

1.5 (47)

3

6.3

6.6/3.6

Yes

Insulin, nifedipine

20

8

38

17w

fibrillary GN

0.6 (116)

1

3.6

5.8/2.6

No

None

22

9

32

6w

Kidney graft

1.2 (60)

2

0.5

6.9/4.0

No

Pred., CyA, ranitidine, ASA,

24

10

20

5w

SLE

0.6 (132)

1

2.5

6.8/3.3

No

Pred.

21

11

37

7w

Kidney graft

1.5 (44)

3

0.8

7.0/3.9

Yes

Pred., CyA, VitD, nifedipine, ASA EPO, ranitidine

27

12

30

6w

IgA GN

1.3 (55)

3

0.7

6.9/4.1

No

Levothyroxine

18.9

13

28

10w

IgA GN

1 (77)

2

2

6.6/3.7

No

None

19.9

14

36

pre; 5w

Diab neph

1 (68)

2

0.6

6.4/4.1

Yes

Lansoprazole, levothyroxine, ASA, Niphedipine, insulin,

21.5

15

35

7w

Diab neph

1.2 (56)

3

0.7

7.4/4.3

No

Insulin

18.2

16

40

24w

Diab neph

0.9 (76)

2

3.1

6.7/3.3

Yes

Insulin, levothyroxine, Nifedipine

24

17

36

20w

IgA GN

1.1 (64)

2

2.4

5.6/4.1

No

None

22.3

18

36

pre; 7w

SLE

2.9 (20)

4

3.4

6.5/3.9

Yes

Pred., levothyroxine, a-MD

24.5

19

38

6w

FSGS

0.6 (116)

1

2.1

6.3/3.3

No

CyA

25

20

33

pre; 8w

Kidney graft

1.3 (52)

3

0.2

7.2/3.9

Yes

Pred, TAC

30

21

31

pre; 9w

Sponge kidney

1.6 (43.3)

3

0.3

6.5/4.0

Yes

ASA, a-MD

23.4

22

33

pre; 7w

Reflux

0.7 (110.4)

1

0.8

6.0/3.7

Yes

ASA, b-bloc

21.8

23

38

pre; 6w

Pyelonephritis

1.2 (59)

3

0.2

6.5/3.9

Yes

a-MD

19.7

24

26

5w

Single kidney, previous HUS

1 (78)

2

0.3

6.8/3.8

Yes

ASA

23.4

25

41

pre; 7w

GN

0.8 (86.6)

2

0.8

7.2/3.8

Yes

ASA

33.6

26

32

6w

IgA GN

1 (74.7)

2

0.6

6.8 /3.9

No

ASA

24.9

27

36

18w

Diab neph

0.7 (106.3)

1

0.9

7.4/4.4

Yes

ASA, a-MD, Insulin

34

28

33

27w

LLAC

0.4 (136.2)

1

1.3

6.0/3.6

Yes

a-MD

29.7

29

33

14w

Unknown

0.8 (105.6)

1

2.2

5.7/3.0

No

ASA

24.8

30

32

30w

Unknown

1.7 (39.6)

3

0.1

6.2/3.6

No

/

26.7

31

31

8 w

Diab neph

1.48 (47)

3

0.1

6.78/4.68

No

ASA, Insulin

19.5

32 (twin)

31

21w

Diab neph

0.5 (128)

1

5.4

5.5/2.8

No

Insulin, levothyroxine

17.9

33 (twin)

37

12w

Unknown

0.7 (112)

1

0.8

7.1/3.5

No

None

31.4

34 (twin)

39

11 w

Previous PNA

0.57 (184.1)

1

0.29

6.11/3.37

No

ASA

32.32

35 (termination)

26

18w

MGN

0.6 (126)

1

5.5

5.1/2.3

No

None

19

36 (miscarriage)

37

7w

Kidney graft

1.7 (38)

3

0.1

6.9/3.9

Yes

Pred., TAC, EPO, ASA, omeprazole, Doxazosin, b-bloc

25.1

Summary data all cases

Median (min-max)

34 (20–41)

7 (5–30)

_

sCr

1.05 (0.4–3.2)

GFR-EPI

66.0 (18.0–184.1)

2 (1–4)

0.8 (0.1–6.3)

Pt

6.5 (5.1–8.4)

Alb

3.75 (2.3–4.68)

17/36

47.2 %

_

23.4 (17.9–34.0)

Summary data

Singletons

Median (min-max)

33

(20–41)

7 (5–30)

_

sCr

1.20 (0.4–3.2)

GFR-EPI

60.0 (18.0–136.2)

3 (1–4)

0.9 (0.1–6.3)

Pt

6.5 (5.6–8.4)

Alb

3.8 (2.6–4.68)

16/31

51.6 %

_

23.4 (18.2–34.0)

  1. Data at referral: data observed at the first follow-up in our unit
  2. HT hypertension, SLE systemic lupus erythematosus, IgA GN IgA nephropathy, FSGS focal segmental glomerlosclerosis, Diab Neph diabetic nephropathy, BMI body mass index, PtU 24 hour proteinuria, sCr serum creatinine, GFR glomerular filtration rate, SLE systemic lupus erythematosus. CyA cyclosporine A, ASA acetyl salicylic acid, Pred. prednisone, TAC tacrolimus, EPO erythropoietin, B-Bloc beta blocker, a-MD alpha methyldopa, ICSI intracytoplasmatic sperm injection